GLP-1RAs Linked to Reduced Uveitis Risk
-
By
-
Jim Gallagher, senior managing editor
-
September 1, 2025
-
3 min
By
Jim Gallagher, senior managing editor
September 1, 2025
Management of endogenous fungal endophthalmitis is complex, with wide variation in treatment strategies. Systemic markers of disease appear to influence the choice of initial therapy more than ocular findings. Although no definitive evidence favors IV over oral systemic therapy, a comprehensive, multidisciplinary approach that considers ocular involvement is essential to optimize patient outcomes in EFE.
January 1, 2026
Understanding interleukin-6 signaling sheds light on novel biologics that could benefit patients with refractory NIU.
September 1, 2025
Joseph P. Shovlin, OD, FAAO, reviewed diagnosis, management, and emerging evidence related to chronic herpetic eye disease prevention at Optometry's Meeting 2026.
June 17, 2026